Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?

On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberc...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Denise Rossato, Mello, Fernanda Carvalho de Queiroz, D’Ambrosio, Lia, Centis, Rosella, Dalcolmo, Margareth Pretti, Migliori, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332832/
https://www.ncbi.nlm.nih.gov/pubmed/33950095
http://dx.doi.org/10.36416/1806-3756/e20210044
Descripción
Sumario:On April 1st, 2020, COVID-19 surpassed tuberculosis regarding the number of deaths per day worldwide. The combination of tuberculosis and COVID-19 has great potential for morbidity and mortality. In addition, the COVID-19 pandemic has had a significant impact on the diagnosis and treatment of tuberculosis. In this review article, we address concurrent tuberculosis and COVID-19, with particular regard to the differences between Brazil and Europe. In addition, we discuss priorities in clinical care, public health, and research.

Ejemplares similares